RNAC insider buying

1 cluster buy

Cartesian Therapeutics, Inc. · Healthcare

When two or more insiders at Cartesian Therapeutics, Inc. buy RNAC on the open market around the same time, that clustered conviction is one of the highest-signal patterns in SEC filing data. Below is every cluster we've detected in RNAC plus the full record of qualifying open-market buys, each parsed directly from Form 4 filings and linked back to the source on SEC EDGAR.

Clusters
1
Distinct insiders
3
Total bought
$15.7M
Market cap
$303.8M

Detected clusters

  • Aug 12, 2024 – Apr 11, 2025
    Detected Apr 11, 2025
    2 insiders
    Total bought
    $15.5M
    Market cap
    $303.8M

All notable open-market buys in RNAC

Every open-market Form 4 purchase, newest first. Click an insider to see their full buying record across companies.

DateInsiderSharesPriceValueFiling
Dec 4, 2025
Director
30,000$6.86$205.8KSEC ↗
Apr 11, 2025
Director, 10% Owner
36,338$10.77$391.4KSEC ↗
Apr 10, 2025
Director, 10% Owner
45,144$10.43$470.9KSEC ↗
Apr 9, 2025
Director, 10% Owner
41,604$9.43$392.3KSEC ↗
Mar 20, 2025
Director, 10% Owner
54,889$15.59$855.7KSEC ↗
Mar 19, 2025
Director, 10% Owner
20,234$14.97$302.9KSEC ↗
Mar 18, 2025
Director, 10% Owner
14,740$14.42$212.6KSEC ↗
Jan 13, 2025
Director, 10% Owner
8,983$17.78$159.7KSEC ↗
Jan 13, 2025
Director, 10% Owner
7,962$16.86$134.2KSEC ↗
Dec 20, 2024
Director, 10% Owner
21,800$18.94$412.9KSEC ↗
Dec 19, 2024
Director, 10% Owner
11,303$17.39$196.6KSEC ↗
Dec 19, 2024
Director, 10% Owner
10,529$18.35$193.2KSEC ↗
Nov 18, 2024
Director, 10% Owner
38,114$17.96$684.5KSEC ↗
Nov 18, 2024
Director, 10% Owner
20,181$18.42$371.7KSEC ↗
Nov 15, 2024
Director, 10% Owner
277,246$17.09$4.7MSEC ↗
Nov 14, 2024
Director, 10% Owner
74,157$16.19$1.2MSEC ↗
Nov 14, 2024
Director, 10% Owner
22,242$16.97$377.4KSEC ↗
Oct 4, 2024
Director, 10% Owner
48,880$22.35$1.1MSEC ↗
Oct 4, 2024
Director, 10% Owner
16,650$23.57$392.4KSEC ↗
Oct 4, 2024
Director, 10% Owner
9,892$21.35$211.2KSEC ↗
Oct 4, 2024
Director, 10% Owner
4,879$23.93$116.8KSEC ↗
Oct 3, 2024
Director, 10% Owner
50,489$20.18$1.0MSEC ↗
Oct 3, 2024
Director, 10% Owner
29,847$18.25$544.7KSEC ↗
Oct 3, 2024
Director, 10% Owner
21,278$21.17$450.5KSEC ↗
Oct 3, 2024
Director, 10% Owner
10,249$19.01$194.8KSEC ↗
3 earlier buys hidden — sign in free to see the full history.

More Healthcare stocks with insider cluster buys

All insider buying in Healthcare

RNAC insider buying — FAQ

Are insiders buying RNAC stock?
Yes — 3 distinct insiders have bought RNAC (Cartesian Therapeutics, Inc.) on the open market, including 1 cluster buy where two or more insiders bought within a rolling window. The most recent qualifying activity was Dec 8, 2025.
How much RNAC stock have insiders bought?
Insiders have bought a combined $15.7M of RNAC across 28 open-market purchases, based on SEC Form 4 filings.
What is an insider cluster buy in RNAC?
A cluster buy is two or more distinct Cartesian Therapeutics, Inc. insiders — officers, directors, or 10% owners — each buying RNAC on the open market within a rolling window. RNAC has 1 detected cluster buy to date.
Where does this RNAC insider trading data come from?
Every figure is parsed directly from SEC Form 4 filings on EDGAR, and each purchase on this page links back to its original filing document.

How we track insider buying in RNAC

We continuously poll SEC EDGAR for new Form 4 filings and parse every open-market purchase (transaction code P). A cluster is recorded when two or more distinct insiders — officers, directors, or 10% owners — each buy RNAC within a rolling window. We track clusters at every company size, from micro-caps to mega-caps. Every figure on this page traces back to an official filing; open any row to jump straight to the source document. What counts as a cluster buy?

This page is informational and reflects public filing data. It is not investment advice or a recommendation regarding RNAC.